{"id":"W2769684200","doi":"10.3324/haematol.2017.175380","title":"Survival adjusting for crossover: phase 3 study of ibrutinib <i>vs</i> . chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2017,"lang":"en","type":"letter","venue":"Haematologica","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pharmacyclics","keywords":"Ibrutinib; Chlorambucil; Chronic lymphocytic leukemia; Internal medicine; Medicine; Leukemia; Lymphoma; Oncology; Hematology; Chemotherapy; Immunology; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003349511,0.0003993891,0.001631677,0.0001605008,0.0005355474,0.0009116239,0.0005620302,0.001615412,0.001384106],"category_scores_gemma":[0.00428006,0.0002787545,0.002130427,0.0005613736,0.0004267091,0.0009196019,0.0002979937,0.002713052,0.0002176967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001028672,"about_ca_system_score_gemma":0.0009646317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001399778,"about_ca_topic_score_gemma":0.002886067,"domain_scores_codex":[0.9986375,0.0008009486,0.00008343966,0.0002272744,0.0001009816,0.0001498475],"domain_scores_gemma":[0.9964538,0.001439783,0.0007728906,0.0004690305,0.0002001487,0.0006642989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8086224,0.003682329,0.0982758,0.0003079534,0.002985296,0.0007983312,0.0002230456,0.0009482036,0.004145926,0.0002932746,0.007898081,0.07181948],"study_design_scores_gemma":[0.3776775,0.1635825,0.4261102,0.0002104884,0.008744106,0.001612485,0.0002923943,0.004087323,0.00217268,0.00247667,0.01290469,0.0001289784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906218,0.003541907,0.0003246587,0.002804726,0.0004283395,0.0001462143,0.0008968172,0.00002857919,0.001206974],"genre_scores_gemma":[0.9934011,0.0008577959,0.0004003893,0.003048818,0.0006775572,0.0001627732,0.0009252895,0.00001010439,0.0005161268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003349511,"threshold_uncertainty_score":0.01771414,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04148799816424028,"score_gpt":0.3180868482053957,"score_spread":0.2765988500411554,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}